|
The account reported finding chloraprep preactivated and reported that the chloraprep seemed to have leaked out of its own package and into the pack, contaminating the rest of the pack's contents.No sample or photo was received for the investigation; the packs production record was reviewed and there were no line down situations, deviations, run-withouts, or non-conformance reports that might have had an impact on this issue, and the bill of materials review found that two chloraprep components are placed in the outerfold of the pack away from the internal components.Without receiving a photo or sample it is unknown what contributed to the reported issue; the reported problem was an unconfirmed defect and the cause was sample required to determine cause.The placement of the chloraprep in the pack was determined to be in a location which provides adequate protection from pre-activation, and the complaint was provided to the vendor for further evaluation while supplier quality will monitor this issue for trending purposes.There were no reports of death, serious injury, medical intervention, or follow up care.It has been determined that the reported event could cause or contribute to serious injury if it were to occur again.In an abundance of caution, this is a reportable event.If additional information becomes available this report will be reopened and reevaluated.This medical device report (mdr) is being submitted as part of retrospective review activities, which include review of historical data in accordance with regulations at 21 cfr part 803.The information included in this mdr reflects the information reasonably known to the manufacturer at the time of this retrospective review and submission.
|